gvtcx

supplier · GB-COH02372699

Octapharma Limited

M21AB combined from 2 published records

Octapharma Limited has won 27 UK public sector awards from 12 buyers since 2016. The typical award is worth £200,000.

as a supplier

27 recorded awards from 12 buyers , between 1 Mar 2016 and 1 Jan 2025.

awards won
27
exclusive
37%
10 sole-winner awards
median award
£200,000
largest
£450m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Octapharma Limited

How many public sector contracts has Octapharma Limited won?

Octapharma Limited has won 27 UK public sector contracts from 12 public bodies since 2016.

Which public bodies buy from Octapharma Limited?

Octapharma Limited has won the most contracts from NHS England, Birmingham Childrens Hospital and The NHS Commissioning Board (operating under the name of NHS England).

How large are Octapharma Limited's contracts?

The median published value of a contract won by Octapharma Limited is £200,000. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Octapharma Limited contracts are expiring soon?

1 contract involving Octapharma Limited has an end date in the next 12 months, the earliest on 30 Apr 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) Norfolk and Norwich University Hospitals NHS Foundation Trust £71,550 1 Jan 2025
NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins shared NHS England £905,187,090 19 Dec 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England £765,000,000 30 May 2024
Octapharma Ltd - Octaplas LG Norfolk and Norwich University Hospitals NHS Foundation Trust £52,500 29 Apr 2023
Blood product required for the treatment of TTP patients University Hospitals of Leicester NHS Trust £97,500 1 Aug 2022
Octaplex Treatment Calderdale and Huddersfield NHS Foundati £100,000 30 Jun 2022
Bleeding Disorders including Haemophilia B shared NHS England £250,000,000 14 Jun 2022
Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England £450,000,000 22 Jun 2021
NHS NATIONAL FRAMEWORK AGREEMENT AGREEMENT FOR HUMAN ALBUMIN SOLUTION (HAS) shared HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST £222,864 25 Apr 2021
Human Albumin shared NHS England £26,400,000 18 Mar 2021
Supply of coagulopathy products BIRMINGHAM WOMENS AND CHILDRENS NHS FOUNDATION TRUST £200,000 23 Feb 2021
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared NHS England £334,400,000 2 Jun 2020
SD Plasma BIRMINGHAM CHILDREN'S HOSPITAL NHS FOUNDATION TRUST £200,000 5 Mar 2019
NHS Framework Agreement for the supply of products for the treatment of Bleeding Disorders shared NHS England £360,000,000 19 Jun 2018
Albumin and Anti-D Immunoglobulin shared Hull & East Yorkshire Hospitals Nhs Trust £225,000 29 Apr 2018
Solvent Detergent Treated FFP BIRMINGHAM CHILDRENS HOSPITAL £175,313 6 Mar 2018
National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders shared NHS England £302,000,000 24 Nov 2017
Octaplas BIRMINGHAM CHILDRENS HOSPITAL £175,313 24 Mar 2017
Octaplas LG BIRMINGHAM CHILDRENS HOSPITAL £149,813 1 Mar 2016
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
Human Derived Blood Products shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · 28 Aug 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins shared NHS England · 13 Mar 2024
NP31518 Albumin Products shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · 12 Jan 2023
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B shared NHS ENGLAND · 15 Dec 2021

every contract won by Octapharma Limited →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Octapharma Limited · M2 1AB 21
Octapharma Ltd GB-COH 02372699 · 6

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 2 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.